Procure radiopharmaceutical products
Ended Awarded
- Contract number
- HT001426FE073
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $501,670
Award facts
- Contract value 100% obligated
- $501,669.60 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a $501,669.60 ceiling delivery order to Novartis Pharmaceuticals Corporation, doing business as NPS, on July 9, 2026, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule to procure radiopharmaceutical products. The order is firm fixed price and was issued with no set-aside. Place of performance is Bethesda, MD 20889, and the period of performance runs from the July 9, 2026 award to an ultimate completion date of July 9, 2026.
Quick answers
Who was awarded contract HT001426FE073?
HT001426FE073 was awarded to Novartis Pharmaceuticals Corporation by Defense Health Agency (Department of Defense) on July 9, 2026.
How much is contract HT001426FE073 worth?
The government has obligated $501,670 on HT001426FE073.
Is contract HT001426FE073 an order under another contract?
Yes. HT001426FE073 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HT001426FE073 competed?
The extent of competition for HT001426FE073 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award